Understanding Prostate Cancer Basics and Why Treatment Matters
Prostate cancer is one of the most common cancers diagnosed in men in the United States. According to the American Cancer Society, about 1 in 8 men will be diagnosed with prostate cancer during their lifetime. The prostate is a small gland about the size of a walnut that is part of the male reproductive system. It produces fluid that helps protect and nourish sperm.
Learn How to Make Water at Home →
When cancer develops in the prostate, cells begin to grow abnormally and multiply out of control. The good news is that many types of prostate cancer grow slowly, and men with prostate cancer often live for many years. However, some forms are more aggressive and can spread to other parts of the body if not treated.
Treatment decisions depend on several factors, including how fast the cancer is growing, how far it has spread, your age, overall health, and your personal preferences about treatment side effects. Some men may not need treatment right away, while others will benefit from starting treatment sooner. Understanding your options helps you work with your doctors to make informed decisions about your care.
The stage of cancer—how far it has spread—is crucial information that guides treatment planning. Doctors use imaging tests, blood tests, and sometimes biopsies to determine the stage. Early-stage prostate cancer confined to the prostate gland has different treatment considerations than cancer that has spread to nearby tissues or distant organs.
Practical Takeaway: Learning the basics about prostate cancer, including your specific diagnosis and stage, forms the foundation for understanding which treatments might be discussed with your medical team.
Active Surveillance: Watching and Monitoring Without Immediate Treatment
Active surveillance is an approach where men with early-stage prostate cancer are monitored closely rather than receiving immediate treatment. This strategy has become increasingly common because research shows that many early prostate cancers grow very slowly and may never cause serious harm during a man's lifetime.
Free Small Block Chevy Headers Selection Guide →
During active surveillance, you will have regular PSA blood tests (usually every 3-6 months), digital rectal exams, and periodic prostate biopsies to check whether the cancer is changing. If tests show that the cancer is growing or becoming more aggressive, your doctor will discuss starting treatment. If the cancer remains stable, you may continue with monitoring for years without needing other therapies.
Active surveillance works well for certain situations. Men with low-risk cancer—meaning small tumors with low PSA levels and low Gleason scores (a measure of how abnormal the cancer cells look)—are good candidates. Men who are older or have other health conditions that limit life expectancy may also benefit from this approach because they may not live long enough for the cancer to become a serious problem.
The benefits of active surveillance include avoiding surgery or radiation side effects, avoiding hormone therapy side effects, and reducing healthcare costs. However, this approach requires commitment to regular monitoring appointments and living with the knowledge that cancer is present. Some men find the uncertainty difficult and prefer to pursue treatment right away.
Studies have shown that men on active surveillance have similar overall survival rates compared to men who receive immediate treatment, at least in the early years after diagnosis. The National Cancer Institute and major cancer organizations recognize active surveillance as a reasonable option for carefully selected patients with low-risk prostate cancer.
Practical Takeaway: If your cancer is diagnosed at an early stage with low-risk features, discussing active surveillance with your doctor can help you understand whether close monitoring without immediate treatment might be an option to explore.
Surgery Options: Radical Prostatectomy and Robotic-Assisted Approaches
Surgery to remove the prostate gland, called radical prostatectomy, is one of the main treatment options for localized prostate cancer. The goal is to remove the entire prostate gland and surrounding tissue to eliminate cancer cells. Surgeons can perform this procedure through different techniques, and the choice depends on factors like tumor size, location, and surgeon experience.
Learn About Appealing Unemployment Insurance Decisions →
Traditional open surgery, called retropubic or perineal prostatectomy, involves making an incision in the lower abdomen or between the scrotum and anus to access and remove the prostate. This approach has been used for decades and remains effective. Surgeons can directly visualize the prostate and surrounding structures during open surgery.
Robotic-assisted laparoscopic prostatectomy has become increasingly popular in recent years. During this procedure, a surgeon operates robotic arms while sitting at a console, viewing a magnified 3D image of the surgical field. The surgeon makes several small incisions rather than one large incision. Benefits of robotic-assisted surgery include smaller incisions, reduced blood loss, less pain after surgery, shorter hospital stays, and faster recovery compared to open surgery. Many patients return to normal activities within 2-3 weeks.
Laparoscopic prostatectomy, performed without robotic assistance, is another minimally invasive option. A surgeon uses long instruments and a camera passed through small incisions to visualize and remove the prostate. This technique requires significant surgeon skill and is less commonly performed than robotic-assisted surgery.
Potential side effects of any prostatectomy procedure include urinary incontinence (inability to control urine), erectile dysfunction (difficulty with erections), and infection. Most men recover urinary control within weeks to months. Erectile function may recover over months to years, though some men experience permanent changes. Nerve-sparing techniques, when appropriate, help preserve the nerves involved in erections.
Success rates are high for surgical treatment of localized prostate cancer. According to the American Urological Association, radical prostatectomy offers good long-term cancer control for appropriate candidates, particularly men with life expectancy of at least 10-15 years.
Practical Takeaway: If surgery is being considered, learning about open, robotic-assisted, and laparoscopic options—including recovery timelines and potential side effects—will help you discuss which approach might be most suitable for your situation.
Radiation Therapy: External Beam and Brachytherapy Options
Radiation therapy uses high-energy X-rays or particles to kill cancer cells and shrink tumors. It is a common treatment for prostate cancer and may be used alone or in combination with other treatments like hormone therapy. Two main types of radiation therapy are used for prostate cancer: external beam radiation therapy (EBRT) and brachytherapy (internal radiation).
Free Guide to Calabasas Senior Center Activities →
External beam radiation therapy delivers radiation from a machine outside the body, similar to getting a CT scan. Treatment is typically given 5 days a week for 7-9 weeks on an outpatient basis. Modern EBRT techniques include intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT). IMRT shapes radiation beams to match the prostate's contour, reducing radiation to surrounding healthy tissue. SBRT delivers higher doses in fewer treatments, sometimes as few as 4-5 sessions, and is sometimes called hypofractionated therapy.
Brachytherapy involves placing radioactive seeds or implants directly into the prostate gland. Low-dose-rate brachytherapy uses seeds that slowly release radiation over weeks. High-dose-rate brachytherapy uses temporary implants inserted for brief treatment sessions, then removed. Brachytherapy is typically recommended for men with early-stage, low-to-intermediate risk cancer and requires only days to weeks of treatment rather than months.
Combination therapy—using both EBRT and brachytherapy together—may be recommended for intermediate-risk or high-risk cancer. Hormone therapy is often combined with radiation therapy for more advanced cancers to improve outcomes.
Side effects of radiation therapy may include urinary symptoms (frequency, urgency, discomfort), bowel symptoms (diarrhea, urgency, bleeding), fatigue, and erectile dysfunction. Most acute side effects improve within weeks to months after treatment ends. Late side effects may develop months or years after treatment and can include chronic urinary or bowel problems. However, modern radiation techniques have reduced the frequency and severity of side effects compared to older approaches.
Radiation therapy effectiveness is high for localized prostate cancer. Studies show that men treated with EBRT or brachytherapy have similar long-term cancer control rates compared to men treated with surgery, particularly when combined with appropriate hormone therapy for intermediate- or high-risk cancers.
Practical Takeaway: Understanding the differences between external beam and b